Cargando…

Pre-Therapeutic Measurements of Iodine Avidity in Papillary and Poorly Differentiated Thyroid Cancer Reveal Associations with Thyroglobulin Expression, Histological Variants and Ki-67 Index

SIMPLE SUMMARY: In the treatment of thyroid cancer, tumour uptake of iodine is important because it enables the use of radioactive iodine to kill cancer tissue. How radioactive iodine treatments are performed is usually determined by the size of the tumour. This study attempted to find new ways of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nilsson, Joachim N., Siikanen, Jonathan, Hedman, Christel, Juhlin, C. Christofer, Ihre Lundgren, Catharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307105/ https://www.ncbi.nlm.nih.gov/pubmed/34298840 http://dx.doi.org/10.3390/cancers13143627

Ejemplares similares

Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up
por: Nilsson, Joachim N, et al.
Publicado: (2023)

Primary tumour iodine avidity in relation to uptake in persistent metastatic disease in papillary and poorly differentiated thyroid cancer
por: Nilsson, Joachim N., et al.
Publicado: (2023)

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer
por: Lindfors, Helene, et al.
Publicado: (2023)

The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer
por: Lindfors, Helene, et al.
Publicado: (2021)

Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report
por: Stenman, Adam, et al.
Publicado: (2021)

Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation – association or random chance?
por: Johansson, Klara, et al.
Publicado: (2021)

High Ki-67 index in fine needle aspiration cytology of follicular thyroid tumors is associated with increased risk of carcinoma
por: Mu, Ninni, et al.
Publicado: (2018)

Minimally invasive follicular thyroid carcinomas: prognostic factors
por: Stenson, Gustav, et al.
Publicado: (2016)

Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center
por: Hellgren, L. Samuel, et al.
Publicado: (2022)

Health Anxiety and Its Relationship to Thyroid-Hormone-Suppression Therapy in Patients with Differentiated Thyroid Cancer
por: Zoltek, Maximilian, et al.
Publicado: (2022)

The Genomic Landscape of Radioactive Iodine Refractory and Avid Papillary Thyroid Carcinomas
por: Al-Kuraya, Khawla Sami, et al.
Publicado: (2021)

Lung carcinoid tumours: histology and Ki‐67, the eternal rivalry
por: Centonze, Giovanni, et al.
Publicado: (2022)

The structure of natively iodinated bovine thyroglobulin
por: Kim, Kookjoo, et al.
Publicado: (2021)

Coexisting iodine avid and iodine nonconcentrating lesions with multiple distant soft tissue metastasis in papillary thyroid cancer
por: Mohapatra, Tushar, et al.
Publicado: (2012)

AN UNUSUAL CASE OF PAPILLARY THYROID CARCINOMA IODINE-131 AVID METASTASIS TO THE ADRENAL GLAND
por: Blažeković, Ivan, et al.
Publicado: (2018)

Quality of Life in Patients with Benign Non-toxic Goiter after Surgical Intervention: A Systematic Review and Meta-Analysis
por: Ihre-Lundgren, Catharina
Publicado: (2022)

Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [(18)F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma
por: Albano, Domenico, et al.
Publicado: (2020)

The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator?
por: Tang, Jingdong, et al.
Publicado: (2018)

Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma
por: Viana, Aline de Oliveira Ribeiro, et al.
Publicado: (2020)

PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma
por: Xing, Xiangling, et al.
Publicado: (2020)

Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry
por: Juhlin, C. Christofer
Publicado: (2021)

MON-495 Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma
por: Viola, Nicola, et al.
Publicado: (2020)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Exploration of thyroglobulin as a biomarker of iodine status in iodine-sufficient and mildly iodine-deficient pregnant women
por: Dineva, Mariana, et al.
Publicado: (2023)

Diagnostic and Prognostic Implications of FGFR3(high)/Ki67(high) Papillary Bladder Cancers
por: Geelvink, Mirja, et al.
Publicado: (2018)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic Indicators
por: Qiu, Zhong-Ling, et al.
Publicado: (2020)

Prognostic impact of Ki-67 in patients with gastric cancer—the importance of depth of invasion and histologic differentiation
por: Ko, Gyung Hyuck, et al.
Publicado: (2017)

Top 10 Histological Mimics of Neuroendocrine Carcinoma You Should Not Miss in the Head and Neck
por: Juhlin, C. Christofer, et al.
Publicado: (2023)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

SAT543 A Case of Non-iodine-Avid Papillary Thyroid Cancer With a Rare Distant Metastasis to the Pancreas
por: Huliganga Alcain, Alistair Marie, et al.
Publicado: (2023)

Invited Commentary: The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer
por: Barczyński, Marcin
Publicado: (2021)

Stimulated Serum Thyroglobulin Levels versus Unstimulated Serum Thyroglobulin in the Follow-up of Patients with Papillary Thyroid Carcinoma
por: Sunny, Saumya Sara, et al.
Publicado: (2018)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Reflection of Dietary Iodine in the 24 h Urinary Iodine Concentration, Serum Iodine and Thyroglobulin as Biomarkers of Iodine Status: A Pilot Study
por: Hlucny, Katelyn, et al.
Publicado: (2021)

Papillary Thyroid Carcinoma with Desmoid-Like Fibromatosis: Double Trouble?
por: Juhlin, C. Christofer, et al.
Publicado: (2022)

Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy
por: Ju, Yanli, et al.
Publicado: (2023)

Can Histological Grade and Mitotic Index Replace Ki67 to Determine Luminal Breast Cancer Subtypes?
por: Oddó, David, et al.
Publicado: (2018)

Histologic correlation of expression of Ki-67 in squamous cell carcinoma of the glottis according to the degree of cell differentiation()
por: Bonhin, Rodrigo Gonzalez, et al.
Publicado: (2014)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_p1k7l4ae82k072ti2l2lrn3mpf